Katsumasa Kuroi

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 99 publications

A phase II study of sequential treatment with anthracycline and taxane followed by eribulin in patients with HER2-negative, locally advanced breast cancer (JBCRG-17).

A phase II study of sequential treatment with anthracycline and taxane followed by eribulin in patients with HER2-negative, locally advanced breast cancer (JBCRG-17).

Journal: Breast cancer research and treatment

Published: June 29, 2021

Long-Term Outcomes of a Randomized Study of Neoadjuvant Induction Dual HER2 Blockade with Trastuzumab and Lapatinib Followed by Weekly Paclitaxel Plus Dual HER2 Blockade for HER2-Positive Primary Breast Cancer (Neo-Lath Study).

Long-Term Outcomes of a Randomized Study of Neoadjuvant Induction Dual HER2 Blockade with Trastuzumab and Lapatinib Followed by Weekly Paclitaxel Plus Dual HER2 Blockade for HER2-Positive Primary Breast Cancer (Neo-Lath Study).

Journal: Cancers

Published: June 23, 2021

Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy.

Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: March 12, 2021

Overnight fasting before lapatinib administration to breast cancer patients leads to reduced toxicity compared with nighttime dosing: a retrospective cohort study from a randomized clinical trial.

Overnight fasting before lapatinib administration to breast cancer patients leads to reduced toxicity compared with nighttime dosing: a retrospective cohort study from a randomized clinical trial.

Journal: Cancer medicine

Published: June 15, 2020

Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the SOLE Trial.

Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the SOLE Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 26, 2020

A randomized, 3-arm, neoadjuvant, phase 2 study comparing docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP), TCbHP followed by trastuzumab emtansine and pertuzumab (T-DM1+P), and T-DM1+P in HER2-positive primary breast cancer.

A randomized, 3-arm, neoadjuvant, phase 2 study comparing docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP), TCbHP followed by trastuzumab emtansine and pertuzumab (T-DM1+P), and T-DM1+P in HER2-positive primary breast cancer.

Journal: Breast cancer research and treatment

Published: November 01, 2019

Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients: extended follow-up of JBCRG-cohort study 01.

Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients: extended follow-up of JBCRG-cohort study 01.

Journal: Breast cancer (Tokyo, Japan)

Published: October 19, 2019

Toxicity of Palbociclib in Patients Aged 70 Years and Older with Metastatic Breast Cancer

Toxicity of Palbociclib in Patients Aged 70 Years and Older with Metastatic Breast Cancer

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: July 13, 2019

Predictive factors of an axillary pathological complete response of node-positive breast cancer to neoadjuvant chemotherapy.

Predictive factors of an axillary pathological complete response of node-positive breast cancer to neoadjuvant chemotherapy.

Journal: Surgery today

Published: April 30, 2019

Ultrasound-guided fine-needle aspiration of axillary lymph nodes in breast cancer: Diagnostic accuracy and role in surgical management.

Ultrasound-guided fine-needle aspiration of axillary lymph nodes in breast cancer: Diagnostic accuracy and role in surgical management.

Journal: Diagnostic cytopathology

Published: March 03, 2019

Effects of molecular crowding environment on the acquisition of toxic properties of wild-type SOD1.

Effects of molecular crowding environment on the acquisition of toxic properties of wild-type SOD1.

Journal: Biochimica et biophysica acta. General subjects

Published: December 28, 2018

Changes in Recurrence Score by neoadjuvant endocrine therapy of breast cancer and their prognostic implication.

Changes in Recurrence Score by neoadjuvant endocrine therapy of breast cancer and their prognostic implication.

Journal: ESMO open

Published: November 20, 2018

Showing 1-12 of 99

Last Updated: 09/26/2026